Medicines Consent Notices




11 MAY 2006

NEW ZEALAND GAZETTE, No. 42

1119

Durogesic 50µg/h
Active Ingredient: Fentanyl 8.4mg
Dosage Form: Transdermal patch
New Zealand Sponsor: Janssen-Cilag Pty Limited
Manufacturer: Alza Ireland Limited, Cashel, Co. Tipperary, Ireland

Durogesic 75µg/h
Active Ingredient: Fentanyl 12.6mg
Dosage Form: Transdermal patch
New Zealand Sponsor: Janssen-Cilag Pty Limited
Manufacturer: Alza Ireland Limited, Cashel, Co. Tipperary, Ireland

Gemzar
Active Ingredient: Gemcitabine hydrochloride 1140mg equivalent to 1000mg Gemcitabine free base
Dosage Form: Powder for infusion
New Zealand Sponsor: Eli Lilly and Company (NZ) Limited
Manufacturers: Lilly France SAS, Fegersheim, France; Lilly Technology Center, Indianapolis, Indiana, United States of America; VIANEX SA, Pallini Attikis, Greece

Gemzar
Active Ingredient: Gemcitabine hydrochloride 228mg equivalent to 200mg Gemcitabine free base
Dosage Form: Powder for infusion
New Zealand Sponsor: Eli Lilly and Company (NZ) Limited
Manufacturers: Lilly France SAS, Fegersheim, France; Lilly Technology Center, Indianapolis, Indiana, United States of America

Dated this 5th day of May 2006.
DON MATHESON, Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on 6 July 2001).

go3113

Renewal of Provisional Consent to the Distribution of New Medicines

Pursuant to section 23 of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the new medicines set out in the Schedule hereto:

Schedule

Product: Luveris
Active Ingredient: Lutropin alfa, rch 75IU
Dosage Form: Powder for injection
New Zealand Sponsor: Pharmacy Retailing (NZ) Limited, t/a Healthcare Logistics
Manufacturer: Laboratoires Serono SA, Aubonne, Switzerland

Note: This consent is valid for two years from 13 May 2006.

Product: Taxotere
Active Ingredient: Docetaxel trihydrate 40mg/mL
Dosage Form: Solution for concentrate for infusion
New Zealand Sponsor: Aventis Pharma Limited
Manufacturers: Aventis Pharma, Rainham, Dagenham, Essex, United Kingdom; Aventis Principes Actifs Pharmaceutiques, Vitry-Sur-Seine, France

Note: This consent is valid for two years from 23 May 2006.

Dated this 5th day of May 2006.
DON MATHESON, Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on 6 July 2001).

go3111

Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:

Schedule

Product: Durogesic 12µg/h
Active Ingredient: Fentanyl 2.1mg
Dosage Form: Transdermal patch
New Zealand Sponsor: Janssen-Cilag Pty Limited
Manufacturer: Alza Ireland Limited, Cashel, Co. Tipperary, Ireland



Next Page →



Online Sources for this page:

VUW Te Waharoa PDF NZ Gazette 2006, No 42


Gazette.govt.nz PDF NZ Gazette 2006, No 42





✨ LLM interpretation of page content

🏥 Consent to the Distribution of Changed Medicines (continued from previous page)

🏥 Health & Social Welfare
5 May 2006
Medicines Act 1981, Consent, Changed Medicines, Durogesic, Gemzar
  • DON MATHESON, Deputy Director-General, Public Health

🏥 Renewal of Provisional Consent to the Distribution of New Medicines

🏥 Health & Social Welfare
5 May 2006
Medicines Act 1981, Provisional Consent, Luveris, Taxotere
  • DON MATHESON, Deputy Director-General, Public Health

🏥 Consent to the Distribution of New Medicines

🏥 Health & Social Welfare
5 May 2006
Medicines Act 1981, Consent, New Medicines, Durogesic
  • DON MATHESON, Deputy Director-General, Public Health